The purpose of the study is to determine whether colchicine is safe and effective in treatment and prevention of recurrent pericarditis after failure of conventional treatment.
Colchicine is safe and effective in the management of recurrent pericarditis after failure of conventional treatment. Preliminary data (observational, non-randomized studies without a control group) have shown that the drug may be effective in treatment of the second and subsequent recurrence and the prevention of further recurrences.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
240
Colchicine 0.5mg BID (\>70Kg) or 0.5 once daily for 6 months
Placebo comparator
Cardiology Department. Maria Vittoria Hospital ASL3 Torino (Coordinating Center)
Torino, Torino, Italy
Azienda Ospedaliera Papa Giovanni XXIII
Bergamo, Italy
Ospedale Regionale
Bolzano, Italy
Ospedale di Rivoli
Rivoli, Italy
Recurrence rate at 18 months
Time frame: 18 m onths
Symptom persistence at 72 hours, remission rate at 1 week. Disease-related re-hospitalization, cardiac tamponade, constrictive pericarditis within the duration of the study.
Time frame: 1 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.